JPMorgan Chase & Co’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.21M Buy
132,912
+106,474
+403% +$971K ﹤0.01% 3623
2025
Q1
$210K Sell
26,438
-154,916
-85% -$1.23M ﹤0.01% 4416
2024
Q4
$985K Buy
181,354
+30,531
+20% +$166K ﹤0.01% 3805
2024
Q3
$1.09M Sell
150,823
-1,049,152
-87% -$7.57M ﹤0.01% 3603
2024
Q2
$13M Buy
1,199,975
+45,259
+4% +$492K ﹤0.01% 1926
2024
Q1
$21.6M Sell
1,154,716
-515,999
-31% -$9.67M ﹤0.01% 1630
2023
Q4
$36.2M Buy
1,670,715
+2,197
+0.1% +$47.6K ﹤0.01% 1267
2023
Q3
$34.3M Sell
1,668,518
-24,076
-1% -$495K ﹤0.01% 1188
2023
Q2
$79.6M Buy
1,692,594
+317,276
+23% +$14.9M 0.01% 869
2023
Q1
$57.7M Sell
1,375,318
-37,513
-3% -$1.57M 0.01% 947
2022
Q4
$53.9M Sell
1,412,831
-115,916
-8% -$4.42M 0.01% 953
2022
Q3
$59.9M Sell
1,528,747
-22,720
-1% -$890K 0.01% 883
2022
Q2
$50.1M Sell
1,551,467
-62,183
-4% -$2.01M 0.01% 959
2022
Q1
$53.4M Buy
1,613,650
+52,028
+3% +$1.72M 0.01% 1025
2021
Q4
$66.4M Buy
1,561,622
+397,001
+34% +$16.9M 0.01% 968
2021
Q3
$51.6M Buy
1,164,621
+22,895
+2% +$1.01M 0.01% 1068
2021
Q2
$64.9M Buy
1,141,726
+12,410
+1% +$705K 0.01% 1013
2021
Q1
$84.5M Sell
1,129,316
-376,759
-25% -$28.2M 0.01% 863
2020
Q4
$130M Sell
1,506,075
-30,001
-2% -$2.6M 0.02% 632
2020
Q3
$91.7M Buy
1,536,076
+145,767
+10% +$8.7M 0.02% 674
2020
Q2
$57.8M Sell
1,390,309
-18,053
-1% -$751K 0.01% 785
2020
Q1
$40.4M Buy
1,408,362
+20,418
+1% +$586K 0.01% 826
2019
Q4
$100M Buy
1,387,944
+465,571
+50% +$33.6M 0.02% 611
2019
Q3
$129M Buy
922,373
+8,172
+0.9% +$1.15M 0.03% 541
2019
Q2
$165M Sell
914,201
-37,867
-4% -$6.83M 0.03% 480
2019
Q1
$151M Buy
952,068
+526
+0.1% +$83.7K 0.03% 482
2018
Q4
$91.1M Buy
951,542
+15,484
+2% +$1.48M 0.02% 599
2018
Q3
$132M Buy
936,058
+3,100
+0.3% +$438K 0.03% 543
2018
Q2
$146M Buy
932,958
+211,272
+29% +$33.1M 0.03% 504
2018
Q1
$116M Sell
721,686
-65,621
-8% -$10.6M 0.02% 542
2017
Q4
$130M Sell
787,307
-50,787
-6% -$8.37M 0.03% 505
2017
Q3
$52.7M Buy
838,094
+19,423
+2% +$1.22M 0.01% 825
2017
Q2
$65.2M Sell
818,671
-15,624
-2% -$1.24M 0.01% 732
2017
Q1
$59.3M Sell
834,295
-164,492
-16% -$11.7M 0.01% 777
2016
Q4
$51M Sell
998,787
-207,757
-17% -$10.6M 0.01% 797
2016
Q3
$55.6M Buy
1,206,544
+130,431
+12% +$6.01M 0.01% 714
2016
Q2
$32.4M Buy
1,076,113
+50,123
+5% +$1.51M 0.01% 955
2016
Q1
$32.9M Buy
1,025,990
+59,582
+6% +$1.91M 0.01% 936
2015
Q4
$56.3M Buy
966,408
+66,948
+7% +$3.9M 0.01% 698
2015
Q3
$38.1M Buy
899,460
+89,822
+11% +$3.8M 0.01% 844
2015
Q2
$59.1M Buy
809,638
+14,846
+2% +$1.08M 0.01% 760
2015
Q1
$39.9M Buy
794,792
+616,721
+346% +$31M 0.01% 929
2014
Q4
$6.52M Buy
178,071
+119,296
+203% +$4.37M ﹤0.01% 1917
2014
Q3
$1.85M Buy
+58,775
New +$1.85M ﹤0.01% 2472